Development of clinical dosage forms for
โ
Ping Li; Sara R. Hynes; Thomas F. Haefele; Madhu Pudipeddi; Alan E. Royce; Abu T
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 706 KB
The solution of a poorly water-soluble drug in a liquid lipid-surfactant mixture, which served as a microemulsion preconcentrate, was converted into a solid form by incorporating it in a solid polyethylene glycol (PEG) matrix. The solid microemulsion preconcentrates thus formed consisted of Capmul P